An Act amending the act of November 21, 2016 (P.L.1318, No.169), known as the Pharmacy Audit Integrity and Transparency Act, further providing for title of act; in preliminary provisions, further providing for definitions; in pharmacy audits, further providing for limitations; and providing for pharmacy benefit manager contract requirements and prohibited acts.

This bill amends the existing Pharmacy Audit Integrity and Transparency Act to impose stricter rules on pharmacy benefit managers and the pharmacies that work with them. The legislation prohibits PBMs from forcing pharmacies to accept lower reimbursement rates to join their networks, banning retroactive money take-backs, and outlawing hidden fees or practices that steer patients toward specific pharmacies solely for cost savings. Additionally, it requires PBMs to respond to pharmacy network requests within 30 days, mandates quarterly reporting on drug rebates, and tasks a state department with regulating PBMs and ensuring pharmacies are reimbursed at least the cost of the drugs they dispense.